Protocol summary
-
Study aim
-
Objective: The aim of the current study is to evaluate the effects of combined vitamin D and evening primrose oil supplementation on metabolic profiles and oxidative stress in women with polycystic ovary syndrome (PCOS).
-
Design
-
Study design: Parallel double-blind (both patients and researchers) randomized controlled clinical trial. Random assignment will be done by the use of computer-generated random numbers.
-
Settings and conduct
-
Population and sample size: 60 patients of eligible and referred to Kosar Clinic affiliated to Arak University of Medical Sciences, Arak, Iran in the study will be selected.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: Women aged 18-40 years diagnosed with PCOS.Exclusion criteria: Elevated levels of prolactin, thyroid disorder, endocrine diseases including individuals with diabetes, impaired glucose tolerance, gastrointestinal diseases.
-
Intervention groups
-
Intervention group: Combined vitamin D and evening primrose oil pearl, 1000 IU vitamin D plus 1000 mg evening primrose oil (Barij Essence, Kashan, Iran), daily, for 12 weeks orally.
Control group: Placebo pearl (Barij Essence, Kashan, Iran), daily, for 12 weeks orally.
-
Main outcome variables
-
Outcomes: Lipid profiles (primary outcomes) and biomarkers of oxidative stress (secondary outcomes) will be measured at study baseline and after 12 weeks of intervention.
General information
-
Reason for update
-
The updating process was done after publishing the paper to correct the registration information.
-
Acronym
-
-
IRCT registration information
-
IRCT registration number:
IRCT201508025623N48
Registration date:
2015-08-06, 1394/05/15
Registration timing:
retrospective
Last update:
2023-04-10, 1402/01/21
Update count:
2
-
Registration date
-
2015-08-06, 1394/05/15
-
Registrant information
-
-
Recruitment status
-
Recruitment complete
-
Funding source
-
Arak University of Medical Sciences
-
Expected recruitment start date
-
2015-08-03, 1394/05/12
-
Expected recruitment end date
-
2015-08-06, 1394/05/15
-
Actual recruitment start date
-
empty
-
Actual recruitment end date
-
empty
-
Trial completion date
-
empty
-
Scientific title
-
Clinical trial of the effect of combined vitamin D and evening primrose oil supplementation on metabolic profiles and oxidative stress in women with polycystic ovary syndrome
-
Public title
-
Effect of supplementation in treatment of women with polycystic ovary syndrome
-
Purpose
-
Treatment
-
Inclusion/Exclusion criteria
-
Inclusion criteria:
Women aged 18-40 years diagnosed with PCOS
Exclusion criteria:
Elevated levels of prolactin
Thyroid disorder
Endocrine diseases including individuals with diabetes, impaired glucose tolerance
Gastrointestinal diseases
-
Age
-
From 18 years old to 40 years old
-
Gender
-
Female
-
Phase
-
3
-
Groups that have been masked
-
- Participant
- Investigator
- Outcome assessor
-
Sample size
-
Target sample size:
60
-
Randomization (investigator's opinion)
-
Randomized
-
Randomization description
-
At study baseline and after stratification for pre-intervention BMI and age, subjects will be randomly divided into two groups to take supplements (n=30) or the standard diet (n=30). Randomization will be done by the use of computer-generated random numbers.
-
Blinding (investigator's opinion)
-
Double blinded
-
Blinding description
-
Participants, investigators or the assessors of the outcomes are unaware of the study groups.
-
Placebo
-
Used
-
Assignment
-
Parallel
-
Other design features
-
Ethics committees
1
-
Ethics committee
-
-
Approval date
-
2015-08-02, 1394/05/11
-
Ethics committee reference number
-
IR.ARAKMU.REC.1394.92
Health conditions studied
1
-
Description of health condition studied
-
Polycystic ovary syndrome
-
ICD-10 code
-
E28.2
-
ICD-10 code description
-
Polycystic ovarian syndrome
Primary outcomes
1
-
Description
-
Triglycerides
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Enzymatic kit
2
-
Description
-
HDL-cholesterol
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Enzymatic kit
3
-
Description
-
Total cholesterol
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Enzymatic kit
4
-
Description
-
LDL
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Enzymatic kit
5
-
Description
-
VLDL
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Enzymatic kit
Secondary outcomes
1
-
Description
-
Serum vitamin D
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Elisa kit
2
-
Description
-
Alopecia
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Clinical observation
3
-
Description
-
Total antioxidant
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Spectrophotometry
4
-
Description
-
Glutathione
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Spectrophotometry
5
-
Description
-
Malondialdehyde
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Spectrophotometry
6
-
Description
-
Modified Ferriman-Gallwey score
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Questionnaire
7
-
Description
-
Acne
-
Timepoint
-
At the beginning of the study and after 12 weeks of intervention
-
Method of measurement
-
Clinical observation
Intervention groups
1
-
Description
-
Intervention group: Combined vitamin D and evening primrose oil pearl, 1000 IU vitamin D plus 1000 mg evening primrose oil, daily, for 12 weeks orally.
-
Category
-
Treatment - Drugs
2
-
Description
-
Control group: Placebo pearl, daily, for 12 weeks orally.
-
Category
-
Treatment - Drugs
1
-
Sponsor
-
-
Grant name
-
-
Grant code / Reference number
-
-
Is the source of funding the same sponsor organization/entity?
-
Yes
-
Title of funding source
-
Arak University of Medical Sciences
-
Proportion provided by this source
-
100
-
Public or private sector
-
Public
-
Domestic or foreign origin
-
Domestic
-
Category of foreign source of funding
-
empty
-
Country of origin
-
-
Type of organization providing the funding
-
Academic
Sharing plan
-
Deidentified Individual Participant Data Set (IPD)
-
Undecided - It is not yet known if there will be a plan to make this available
-
Study Protocol
-
Undecided - It is not yet known if there will be a plan to make this available
-
Statistical Analysis Plan
-
Undecided - It is not yet known if there will be a plan to make this available
-
Informed Consent Form
-
Undecided - It is not yet known if there will be a plan to make this available
-
Clinical Study Report
-
Undecided - It is not yet known if there will be a plan to make this available
-
Analytic Code
-
Undecided - It is not yet known if there will be a plan to make this available
-
Data Dictionary
-
Undecided - It is not yet known if there will be a plan to make this available